Effects of a Low Molecular Weight Heparin,Bemiparin,and Unfractionated Heparin on Hemostatic Properties of Endothelium

Abstract

Human endothelial cells synthesize and secrete a variety of molecules involved in fibrinolysis and coagulation. The effects of a low molecular weight heparin, Bemiparin, and unfractionated heparin (UFH) were compared on plasminogen activator inhibitor-i (PAI-1), tissue-plasminogen activator (t-PA), tissue factor (TF), tissue factor pathway inhibitor (TFPI) release, and PAl-i gene expression by human umbilical vein endothelial cells (HUVEC). Cell cultures were supplemented with Bemiparin or UFH at 1 or 10 U/mL. Culture media samples were obtained before the addition of the drugs and 2, 6, and 24 hours afterward to measure the antigen levels of TF, TFPI, t-PA, and PAI-1. RNA was obtained to study the endothelial expression of PAM by reverse transcriptase-polymerase chain reaction (RT-PCR). Bemiparin at 1 U/mL resulted in a decreased messenger RNA (mRNA) PAI-I expression, which remained unaltered when UFH had been added. PAM-levels increased after the cultures had been supplemented with either Bemiparin or UFH at both doses. UFH induced an increase in t-PA either at 1 or 10 U/mL. Both doses of UFH, but not Bemiparin, induced an important increase in TF secretion. An increase in the TFPI levels was seen with UFH at 1 U/mL. The decrease in PAM-i gene expression observed with a therapeutic dose of Bemiparin might confer this drug interesting profibrinolytic properties. The fact that Bemiparin, in contrast with UFH, does not induce an increase in TF could give this drug another positive feature.

Keywords

Bemiparin Unfractionated heparin HUVEC Plasminogen activator inhibitor-i Tissue factor Tissue factor path-way inhibitor

References

1. Cines DB , Pollak ES , Buck CA , et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-3527.

2. Orbe J , Montes R , Zabalegui N , et al. Evidence that heparin but not hirudin reduces PAL-i expression in cultured human endothelial cells. Thromb Res 1999;94:137-137.

3. Jaffe EA , Nachman RL , Becker CG , Minick CR . Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2745.

4. Orbe J , Chorda C , Montes R , Paramo JA . Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1 alpha. Haematologica 1999;84:306-306.

5. Vergnes C , Manciet G , Bourdenx V , et al. Standard heparin but not LMW heparin induces a concomitant increase of t-PA and PAI-1 without modification of global fibrinolysis: Study after 60 days treatment. Thromb Res 1991;63:521-521.

6. Suzuki S , Matsuo T , Kobayashi H , et al. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: Effects on inflammatory, hemostatic, and endothelium-derived parameters. Thromb Res 2000;98:269-269.

7. Gori AM , Pepe G , Attanasio M , et al. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration. Thromb Haemost 1999;81:589-589.

8. Soejima H , Ogawa H , Yasue H , et al. Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris. Thromb Res 1999;93:17-17.

9. Nguyen P , Remy MG , Potron G . Comparative inhibition of LPS-activated human monocyte-induced thrombin generation by unfractionated heparin and low molecular weight heparins. Haemostasis 1999;29:301-301.

10.

10. Barstad RM , Hamers MJ , Moller AS , Sakariassen KS . Monocyte procoagulant activity induced by adherence to an artificial surface is reduced by end-point immobilized heparin-coating of the surface. Thromb Haemost 1998;79:302-302.

11.

11. Bendz B , Hansen JB , Andersen TO , et al. Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins. Br J Haematol 1999; 107:756-756.

12.

12. Hansen JB , Svensson B , Olsen R , et al.Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro. Thromb Haemost 2000;83:937-937.

13.

13. Giraux JL , Tapon-Bretaudiere J , Matou S , Fischer AM . Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells. Thromb Haemost 1998;80:692-692.

14.

14. Lupu C , Poulsen E , Roquefeuil S , et al. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. Arterioscler Thromb Vasc Biol 1999;19:2251-2251.

15.

15. Pendurthi UR , Rao LV , Williams JT , Idell S . Regulation of tissue factor pathway inhibitor expression in smooth muscle cells. Blood 1999;94:579-579.